Fundz

N-Power Medicine raised $72 Million in a Series B funding round led by Merck Global Health Innovation Fund

PRIVATEJul 01, 2024

Amount Raised

$72 Million

Round Type

Series B

Redwood CityBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Investors

A Us Based Healthcare Focused InvestorMerck Global Health Innovation Fund

Description

N-Power Medicine, a clinical research and drug development platform company, has announced the initial close of its Series B funding round, with participation by a US-based healthcare focused investor. The funding round led by Merck Global Health Innovation Fund brings its total funding to date to $72 Million.

Company Information

Company

N-Power Medicine

Location

Redwood City, California, United States

About

N-Power Medicine is a clinical research and drug development platform company that aims to integrate clinical research and routine care into a single workflow. Founded in 2021, it aims to boost clinical trial participation to accelerate oncology drug development. The company's platform includes The Kaleido Registry, a collection of prospective, real-time, standardized patient data designed to support clinical trials and drug development.

Fundz sees it the moment N-Power Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsMark, CEO & Co-Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for N-Power Medicine's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

N-Power Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.